Decimate-C Anticancer Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-01-2025
- Paid Up Capital ₹ 0.10 M
as on 01-01-2025
- Company Age 12 Year, 7 Days
- Last Filing with ROC 31 Mar 2022
- Revenue -56.11%
(FY 2022)
- Profit -405.38%
(FY 2022)
- Ebitda -6.83%
(FY 2022)
- Net Worth -79.31%
(FY 2022)
- Total Assets -75.10%
(FY 2022)
About Decimate-C Anticancer Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arundhati Ranade, Prerana Patil, and Rhucha Dasare serve as directors at the Company.
- CIN/LLPIN
U85100PN2012NPL145805
- Company No.
145805
- Company Classification
Private Not For Profit Company
- Incorporation Date
27 Dec 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Decimate-C Anticancer Foundation?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arundhati Ranade  | Director | 17-Jan-2017 | Current |
| Prerana Patil | Director | 18-Dec-2019 | Current |
| Rhucha Dasare | Director | 18-Dec-2019 | Current |
Financial Performance of Decimate-C Anticancer Foundation.
Decimate-C Anticancer Foundation, for the financial year ended 2022, experienced significant reduction in revenue, with a 56.11% decrease. The company also saw a substantial fall in profitability, with a 405.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 79.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Decimate-C Anticancer Foundation?
In 2020, Decimate-C Anticancer Foundation had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Decimate-C Anticancer Foundation?
Unlock and access historical data on people associated with Decimate-C Anticancer Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Decimate-C Anticancer Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Decimate-C Anticancer Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
